management cystic fibrosis observation gentamycin used antibiotic pulmonary infection associated cystic fibrosis 1971 1973 hospitalized 41 symptomatic patient cystic fibrosis intensive pulmonary therapy severely ill patient admitted period study included 100 course intensive treatment garamycin pediatric injectable containing 10 mgml active ingredient administered intravenously patient divided dos 30 50 mgkgday purpose study evaluate tolerance pharmacokinetics efficacy garamycin administered parenterally cystic fibrosis patient serious infection 100 course treatment clinical improvement rated follows significant definite improvement 39 moderate improvement 50 slight improvement 9 change 2 use garamycin pediatric injectable safe helpful management pulmonary infectious complication cystic fibrosis employed along wellestablished modality therapy